Omada Health Inc (OMDA) Stock Price, Trades & News

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	7.07
Equity-to-Asset	0.77
Debt-to-Equity	0.13
Debt-to-EBITDA	35.51
Piotroski F-Score	N/A/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	10.4	Distress Grey Safe
Beneish M-Score	-2.58	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	56
	3-Year EBITDA Growth Rate	54.1
	3-Year EPS without NRI Growth Rate	45.5
	Future 3-5Y Total Revenue Growth Rate Estimate	21.42

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	91.77
	9-Day RSI	81.25
	14-Day RSI	74.92
	3-1 Month Momentum %	22.15
	6-1 Month Momentum %	0.94
	12-1 Month Momentum %	-9.9

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	3.92
	Quick Ratio	3.87
	Cash Ratio	3.08
	Days Inventory	13.73
	Days Sales Outstanding	17.79
	Days Payable	27.46

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-1.6
	Shareholder Yield %	-13.1

Profitability Rank

1/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	66.27
	Operating Margin %	-2.95
	Net Margin %	-2.22
	EBITDA Margin %	0.3
	FCF Margin %	5.79
	OCF Margin %	7.95
	ROE %	-3.3
	ROA %	-2.35
	ROIC %	-12.91
	3-Year ROIIC %	243.92
	ROC (Joel Greenblatt) %	-65.47
	ROCE %	-2.37
	Moat Score	4

GF Value Rank

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	298.43
	PS Ratio	3.17
	PB Ratio	5.29
	Price-to-Tangible-Book	5.65
	Price-to-Free-Cash-Flow	63.3
	Price-to-Operating-Cash-Flow	44.35
	EV-to-EBIT	-217.48
	EV-to-EBITDA	1242.53
	EV-to-Forward-EBITDA	-858.18
	EV-to-Revenue	3.7
	EV-to-Forward-Revenue	3.22
	EV-to-FCF	63.96
	Price-to-Net-Current-Asset-Value	6.16
	Price-to-Net-Cash	8.63
	Earnings Yield (Greenblatt) %	-0.46
	FCF Yield %	1.32

GF Value™

OMDA

Warning Signs

Warning! GuruFocus detected 1 Medium warning sign with OMDA. Try a 7-Day Free Trial to check it out.

Omada Health Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Omada Health Inc Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings conference call for 2026	2026-11-06 16:30	In 131 days
Third quarter earnings results for 2026	2026-11-06	In 130 days
Second quarter earnings conference call for 2026	2026-08-07 16:30	In 40 days
Second quarter earnings results for 2026	2026-08-07	In 39 days
General meeting for 2025	2026-06-16 09:00	17.33 (-0.35%)
Goldman Sachs 47th Annual Global Healthcare Conference	2026-06-10 20:20	18.32 (+2.46%)
First quarter earnings conference call for 2026	2026-05-07 16:30	15.86 (+0.57%)
First quarter earnings results for 2026	2026-05-07	15.86 (+0.57%)
Annual report for 2025	2026-03-06	13.60 (+0.74%)
Fourth quarter earnings conference call for 2025	2026-03-05 16:30	13.52 (+3.68%)

Show

Entries

Guru Commentaries on NAS:OMDA

No articles.

Press Release

	Subject	Date
No Press Release

Articles on Omada Health Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.